Comprehensive Guide to LAMS (Spaxus - 8mm) for Gallbladder Intervention

The evolution of interventional endoscopy has been defined by the transition from invasive surgical procedures to minimally invasive, lumen-apposing alternatives. Among these, the Lumen-Apposing Metal Stent (LAMS), specifically the Spaxus 8mm system, represents a significant leap forward in the management of gallbladder pathologies. Designed to bridge the gap between traditional cholecystectomy and percutaneous drainage, the Spaxus 8mm LAMS provides a robust, safe, and effective pathway for EUS-guided gallbladder drainage (EUS-GBD).

This guide serves as a comprehensive technical and clinical resource for gastroenterologists, interventional endoscopists, and surgical staff involved in the application of this specialized device.

Technical Specifications and Mechanism of Action

The Spaxus 8mm LAMS is engineered to facilitate secure apposition between the gallbladder wall and the gastrointestinal tract (duodenal bulb or gastric antrum). Its design focuses on preventing stent migration while maintaining lumen patency.

Core Design Features

Biomechanics and Tissue Interaction

The use of Nitinol provides the Spaxus LAMS with "shape-memory" properties. Upon deployment, the stent expands to its programmed diameter, and the bilateral flanges exert radial force against the visceral walls. This creates a "dumbbell" configuration that holds the gallbladder wall firmly against the GI tract wall. This tension is critical, as it prevents leakage of bile or gallbladder content into the peritoneal cavity, effectively creating a "fistula" that is sealed by the stent itself.

Clinical Indications and Procedural Applications

The 8mm Spaxus LAMS is primarily indicated for patients suffering from acute cholecystitis who are deemed high-risk for surgery due to advanced age, severe comorbidities, or American Society of Anesthesiologists (ASA) class III/IV status.

Primary Indications

1. Acute Calculous Cholecystitis: In patients unfit for urgent cholecystectomy.
2. Inoperable Gallbladder Malignancy: For palliative drainage to relieve obstruction.
3. Recurrent Cholecystitis: In patients with high surgical risk who require long-term biliary decompression.

Procedural Workflow

The EUS-guided approach using the Spaxus system involves:
* EUS Localization: Identification of the gallbladder via endoscopic ultrasound from the stomach or duodenum.
* Access: Using the electrocautery-enhanced tip of the delivery system to puncture the gallbladder wall under EUS guidance.
* Deployment: The distal flange is deployed within the gallbladder, followed by the withdrawal of the delivery system and deployment of the proximal flange within the GI lumen.
* Confirmation: Immediate visual confirmation of bile flow through the stent.

Fitting, Usage, and Maintenance Protocols

Successful utilization of the Spaxus 8mm system requires strict adherence to institutional protocols regarding sterilization and handling.

Usage Instructions

1. Preparation: Ensure the delivery system is compatible with the therapeutic endoscope's working channel (typically 3.7mm or larger).
2. Safety Checks: Inspect the stent delivery catheter for any kinks or damage prior to insertion.
3. Sterilization: The Spaxus LAMS is a single-use, sterile device. It must never be re-sterilized or reused.
4. Storage: Keep in a cool, dry environment, protected from direct sunlight and extreme temperature fluctuations, which could compromise the Nitinol properties.

Risks, Side Effects, and Contraindications

While the 8mm Spaxus LAMS is highly effective, clinicians must be aware of the inherent risks associated with EUS-guided drainage.

Potential Adverse Events

• Stent Migration: Rare, but can occur if the gallbladder wall is thin or if the stent is undersized relative to the tissue thickness.
• Infection (Cholangitis): If the stent becomes occluded by debris or stones.
• Perforation: Risk of accidental puncture of non-target structures (e.g., blood vessels).
• Bleeding: Risk associated with the electrocautery puncture site.

Contraindications

• Coagulopathy that cannot be corrected.
• Gallbladder anatomy that does not allow for close apposition to the GI wall.
• Severe anatomical distortion of the stomach or duodenum.

Patient Outcome Improvements

The shift toward the Spaxus 8mm LAMS has fundamentally altered patient recovery trajectories. Compared to percutaneous cholecystostomy, EUS-GBD with LAMS offers several advantages:

1. Reduced Hospital Stay: Patients typically experience faster recovery times.
2. Quality of Life: Elimination of the external drainage catheter, which is often a source of discomfort and risk of infection for patients.
3. Lower Re-intervention Rates: The secure apposition provided by the LAMS reduces the risk of recurrent infection compared to plastic pigtail stents.
4. Surgical Bridging: In many cases, the LAMS provides a safe "bridge" that allows for interval cholecystectomy once the patient's systemic inflammatory state has stabilized.

Frequently Asked Questions (FAQ)

1. Why is 8mm the preferred diameter for the Spaxus LAMS?

The 8mm diameter provides an optimal balance between sufficient flow for biliary drainage and the mechanical stability required to prevent stent migration.

2. Is the Spaxus stent removable?

Yes, the Spaxus LAMS is designed for temporary use. It can be removed endoscopically once the gallbladder inflammation has resolved or prior to interval surgery.

3. What is the role of the electrocautery tip?

The integrated electrocautery tip allows the endoscopist to perform the puncture and stent deployment in a single step, reducing the need for multiple accessory exchanges.

4. How long can the LAMS remain in situ?

Typically, the stent is left in place for 4 to 8 weeks, depending on the clinical resolution of the cholecystitis.

5. Can this device be used in patients with ascites?

Great caution is advised. Large amounts of ascites increase the risk of gallbladder-to-GI tract separation, which can lead to peritonitis.

6. What imaging modality is required during the procedure?

EUS (Endoscopic Ultrasound) is essential for visualization, and fluoroscopy is often used as an adjunct to confirm stent position.

7. Does the stent require a specific type of endoscope?

It requires a therapeutic endoscope with a large working channel (min. 3.7mm) to accommodate the delivery catheter.

8. What are the signs of stent occlusion?

Patients may present with recurrent fever, abdominal pain, or elevated white blood cell counts, indicating that the stent is clogged with gallbladder sludge or stones.

9. Is sedation required for this procedure?

Yes, EUS-GBD is performed under deep sedation or general anesthesia to ensure patient stability and safety.

10. How does LAMS compare to plastic stents?

LAMS provides larger luminal patency and better tissue apposition, significantly reducing the risk of stent migration and secondary infection compared to conventional plastic stents.

Conclusion

The Spaxus 8mm LAMS has solidified its place as a cornerstone of modern endoscopic intervention. By providing a secure, reliable, and minimally invasive solution for gallbladder drainage, it has dramatically improved outcomes for high-risk patients. Continued training in EUS-guided techniques and strict adherence to procedural safety protocols remain the best ways to maximize the benefits of this innovative orthopedic-adjacent medical technology. As surgical paradigms shift toward less invasive interventions, the mastery of the Spaxus system is an essential skill for the modern interventionalist.